New York, United States, July 19, 2022 (GLOBE NEWSWIRE) — Autoimmune disease (AD) is a non-communicable disease that revolves around losing normal immune homeostasis. This organism is responsible for producing an irregular response for its tissue cells. Furthermore, autoimmune diseases revolve around the activation of self-reactive T cells, autoantibodies, and inflammation. Typically, immune cells can identify alien objects such as bacteria and viruses and send out fighter cells to counter their presence. Autoimmune diseases compel the immune system to attack itself. Some autoimmune diseases attack only a certain type of organ.
Rising prevalence of chronic diseases coupled with increasing patient pool are fueling the market growth. Growing public attention and increasing autoimmune disease intensity among the elderly population to boost the autoimmune disease diagnostics market growth.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/autoimmune-disease-diagnostics-market/request-sample
Key Insights
- The global autoimmune disease diagnostics market was valued at USD 4,253.29 million in 2021, and is anticipated to generate 8089.97 million by 2030 at a CAGR of 7.25% by 2030.
- The market is categorized into systemic autoimmune disease and localized autoimmune disease based on disease type. Localized autoimmune disease is predicted 5209.99 million by 2030 at a CAGR 7.05% during the forecast period.
- By diagnosis, the market is…
